1st Michigan patient undergoes FDA-authorized sickle cell gene therapy

Chantez Sanford Jr., 24, of Southfield, says his life has been transformed after undergoing Lyfgenia gene therapy at Children ...
FOX 2 Detroit on MSN

Sickle Cell disease treatment hits medical breakthrough in Detroit

It’s a medical breakthrough in treating sickle cell disease and a Michigan man is proof that it works.

Nemours Children's Hospital offers new gene therapy for sickle cell

Nemours Children's Hospital is now offering Lyfgenia gene therapy. The treatment aims to reduce pain crises and hospital visits for young patients.

Man receives gene therapy to cure sickle cell disease, hopes to become licensed pilot

Daniel Cressy says today is a life-changing day. The man in his 20s received a gene therapy transfusion Wednesday at Manning ...
Medical Xpress

Gene therapy reduces stroke risk factors in sickle cell disease patients

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude Children's Research Hospital. Many people with sickle ...
The American Journal of Managed Care

Gene Therapy Meaningfully Improves Quality of Life in Severe Sickle Cell Disease

Exagamglogene autotemcel (exa-cel) significantly improved HRQOL in severe SCD patients, eliminating severe VOCs and hospitalizations in most cases. The CLIMB SCD-121 trial showed sustained ...
News Medical

Breakthrough gene therapy for sickle cell disease remains out of reach in Africa

As Uganda rolls out mandatory nationwide screening of newborns for sickle cell disease this month, a gene therapy celebrated in the United States and Europe remains financially out of reach for most ...
WWMT

How Michigan is addressing lack of accessible, consistent care for sickle cell disease

State health officials have a new plan on addressing one of Michigan's most prevalent genetic disorders. Michigan Department ...
Medscape

Sickle Cell Gene Therapy 'Truly Transformative'

SAN DIEGO — A newly approved gene therapy product for sickle cell disease, lovotibeglogene autotemcel (lovo-cel, marketed as Lyfgenia), led to durable disease remissions for up to 5 years and almost ...
ABC7

FDA-approved gene therapies bring hope for sickle cell patients, but high costs pose challenges

LOS ANGELES (KABC) -- It's been more than a month since the FDA approved two milestone gene-editing treatments for sickle cell disease, but lining up patients for these therapies will be a challenge ...

Sickle Cell Care Reaches an Inflection Point as Gene Therapy Enthusiasm Rises, but Referral Pathways and Uptake Lag Amid Due to Treatment Burden

On average, patients included in the audit are taking nearly six medications, reflecting a high degree of polypharmacy and complex chronic disease management typical of moderate-to-severe sickle cell ...
News Medical

Gene therapy shows promise for reducing stroke risk in patients with sickle cell disease

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude Children's Research Hospital. Many people with sickle ...